Abstract 9866: Novel Oral Anticoagulants versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Valvular Heart Disease: A Systematic Review and Meta-Analysis
2021
Background: Currently, vitamin-K antagonists (VKAs) are the anticoagulant of choice for treating atrial fibrillation (AF) patients with valvular heart disease (VHD). Novel oral anticoagulants (NOAC...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI